NEW YORK – The Association for Molecular Pathology on Tuesday published best practice recommendations for the design and validation of clinical tests for homologous recombination deficiency. The ...

RAD51C or RAD51D gene; BRIP1 gene; PALB2 gene; Having one of these faulty genes means that you are more likely to get ovarian cancer than someone who doesn’t. But it is not a certainty. Having certain ...

The Stuart and Molly Sloan Precision Oncology Institute invited investigators at Fred Hutch Cancer Center, University of Washington and Seattle Children’s Research Institute to submit innovative, ...

In another, more recent paper, researchers at the Wellcome Sanger Institute in the U.K. reported identifying more than 3,000 genetic changes in the RAD51C gene, which is also crucial for DNA ...

Researchers at the Wellcome Sanger Institute have identified over 3,000 genetic variants in the RAD51C gene that significantly increase the risk of breast and ovarian cancer. This study shows risk ...

The RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast and ovarian cancers and rarely, ...

The RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast and ovarian cancers and rarely, ...

The Role of RAD51C in Cancer Development. The RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast ...

London [UK], September 19 (ANI): Researchers have identified thousands of genetic variants in a gene that could raise an individual’s risk of ovarian and breast cancer, opening the door to more ...

The RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast and ovarian cancers and rarely, if there are ...

Rebeca Olvera-León, first author of the study at the Wellcome Sanger Institute, said: “This research demonstrates that genetic risk for breast and ovarian cancer isn't a simple yes-or-no scenario, but ...